These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 25430934)

  • 41. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity.
    Young P; Grote K; Kuhlenbäumer G; Debus O; Kurlemann H; Halfter H; Funke H; Ringelstein EB; Stögbauer F
    J Neurol; 2001 May; 248(5):410-5. PubMed ID: 11437164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular basis of Charcot-Marie-Tooth neuropathy].
    Hayasaka K
    Nihon Rinsho; 1996 Aug; 54(8):2243-51. PubMed ID: 8810804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variants.
    Record CJ; Skorupinska M; Laura M; Rossor AM; Pareyson D; Pisciotta C; Feely SME; Lloyd TE; Horvath R; Sadjadi R; Herrmann DN; Li J; Walk D; Yum SW; Lewis RA; Day J; Burns J; Finkel RS; Saporta MA; Ramchandren S; Weiss MD; Acsadi G; Fridman V; Muntoni F; Poh R; Polke JM; Zuchner S; Shy ME; Scherer SS; Reilly MM;
    Brain; 2023 Oct; 146(10):4336-4349. PubMed ID: 37284795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of PMP22, GJB1 and MPZ in Greek Charcot-Marie-Tooth type 1 neuropathy patients.
    Karadima G; Floroskufi P; Koutsis G; Vassilopoulos D; Panas M
    Clin Genet; 2011 Nov; 80(5):497-9. PubMed ID: 22243284
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic epidemiology, demographic, and clinical characteristics of Charcot-Marie-tooth disease in the island of Gran Canaria (Spain).
    Lousa M; Vázquez-Huarte-Mendicoa C; Gutiérrez AJ; Saavedra P; Navarro B; Tugores A
    J Peripher Nerv Syst; 2019 Mar; 24(1):131-138. PubMed ID: 30569560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [PCR in the gene diagnosis of Charcot-Marie-Tooth disease].
    Xiao J; Tang B; Xia J
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):138-41. PubMed ID: 11798863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sonography of the median nerve in CMT1A, CMT2A, CMTX, and HNPP.
    Schreiber S; Oldag A; Kornblum C; Kollewe K; Kropf S; Schoenfeld A; Feistner H; Jakubiczka S; Kunz WS; Scherlach C; Tempelmann C; Mawrin C; Dengler R; Schreiber F; Goertler M; Vielhaber S
    Muscle Nerve; 2013 Mar; 47(3):385-95. PubMed ID: 23381770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation.
    Boerkoel CF; Takashima H; Garcia CA; Olney RK; Johnson J; Berry K; Russo P; Kennedy S; Teebi AS; Scavina M; Williams LL; Mancias P; Butler IJ; Krajewski K; Shy M; Lupski JR
    Ann Neurol; 2002 Feb; 51(2):190-201. PubMed ID: 11835375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Charcot-Marie-Tooth disease subtypes and genetic testing strategies.
    Saporta AS; Sottile SL; Miller LJ; Feely SM; Siskind CE; Shy ME
    Ann Neurol; 2011 Jan; 69(1):22-33. PubMed ID: 21280073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.
    Nelis E; Van Broeckhoven C; De Jonghe P; Löfgren A; Vandenberghe A; Latour P; Le Guern E; Brice A; Mostacciuolo ML; Schiavon F; Palau F; Bort S; Upadhyaya M; Rocchi M; Archidiacono N; Mandich P; Bellone E; Silander K; Savontaus ML; Navon R; Goldberg-Stern H; Estivill X; Volpini V; Friedl W; Gal A
    Eur J Hum Genet; 1996; 4(1):25-33. PubMed ID: 8800924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies.
    Silander K; Meretoja P; Juvonen V; Ignatius J; Pihko H; Saarinen A; Wallden T; Herrgård E; Aula P; Savontaus ML
    Hum Mutat; 1998; 12(1):59-68. PubMed ID: 9633821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
    Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
    JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.
    Rudnik-Schöneborn S; Tölle D; Senderek J; Eggermann K; Elbracht M; Kornak U; von der Hagen M; Kirschner J; Leube B; Müller-Felber W; Schara U; von Au K; Wieczorek D; Bußmann C; Zerres K
    Clin Genet; 2016 Jan; 89(1):34-43. PubMed ID: 25850958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic evaluation of inherited motor/sensory neuropathy.
    Chance PF
    Suppl Clin Neurophysiol; 2004; 57():228-42. PubMed ID: 16106622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families.
    Mostacciuolo ML; Righetti E; Zortea M; Bosello V; Schiavon F; Vallo L; Merlini L; Siciliano G; Fabrizi GM; Rizzuto N; Milani M; Baratta S; Taroni F
    Hum Mutat; 2001; 18(1):32-41. PubMed ID: 11438991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan.
    Abe A; Numakura C; Kijima K; Hayashi M; Hashimoto T; Hayasaka K
    J Hum Genet; 2011 May; 56(5):364-8. PubMed ID: 21326314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A.
    Xu IRL; Danzi MC; Ruiz A; Raposo J; De Jesus YA; Reilly MM; Cortese A; Shy ME; Scherer SS; Herrmann DN; Fridman V; Baets J; Saporta M; Seyedsadjadi R; Stojkovic T; Claeys KG; Patel P; Feely S; Rebelo AP; ; Dohrn MF; Züchner S
    J Peripher Nerv Syst; 2024 Jun; 29(2):202-212. PubMed ID: 38581130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study.
    Fridman V; Sillau S; Bockhorst J; Smith K; Moroni I; Pagliano E; Pisciotta C; Piscosquito G; Laurá M; Muntoni F; Bacon C; Feely S; Grider T; Gutmann L; Shy R; Wilcox J; Herrmann DN; Li J; Ramchandren S; Sumner CJ; Lloyd TE; Day J; Siskind CE; Yum SW; Sadjadi R; Finkel RS; Scherer SS; Pareyson D; Reilly MM; Shy ME;
    Ann Neurol; 2023 Mar; 93(3):563-576. PubMed ID: 36203352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CMT1X phenotypes represent loss of GJB1 gene function.
    Shy ME; Siskind C; Swan ER; Krajewski KM; Doherty T; Fuerst DR; Ainsworth PJ; Lewis RA; Scherer SS; Hahn AF
    Neurology; 2007 Mar; 68(11):849-55. PubMed ID: 17353473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.